DiaMedica Therapeutics (NASDAQ:DMAC – Get Rating) and IO Biotech (NASDAQ:IOBT – Get Rating) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their institutional ownership, profitability, analyst recommendations, dividends, valuation, earnings and risk. Analyst Ratings This is a summary of recent ratings […]
DiaMedica Therapeutics Inc. (NASDAQ:DMAC – Get Rating) was the target of a significant drop in short interest in April. As of April 30th, there was short interest totalling 91,900 shares, a drop of 5.6% from the April 15th total of 97,400 shares. Based on an average daily trading volume, of 27,100 shares, the days-to-cover ratio […]
DiaMedica Therapeutics (NASDAQ:DMAC – Get Rating) and Marinus Pharmaceuticals (NASDAQ:MRNS – Get Rating) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, earnings, analyst recommendations, risk, profitability, dividends and valuation. Volatility and Risk DiaMedica Therapeutics has a beta of […]
DiaMedica Therapeutics (NASDAQ:DMAC – Get Rating) and 9 Meters Biopharma (NASDAQ:NMTR – Get Rating) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, profitability, risk, analyst recommendations, dividends, valuation and institutional ownership. Analyst Ratings This is a breakdown of current […]
DiaMedica Therapeutics (NASDAQ:DMAC – Get Rating) and 9 Meters Biopharma (NASDAQ:NMTR – Get Rating) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, profitability, risk, earnings, analyst recommendations, dividends and valuation. Volatility & Risk DiaMedica Therapeutics has a beta […]